Seo, Y.; Kim, J.; Park, S.J.; Park, J.J.; Cheon, J.H.; Kim, W.H.; Kim, T.I.
Metformin Suppresses Cancer Stem Cells through AMPK Activation and Inhibition of Protein Prenylation of the Mevalonate Pathway in Colorectal Cancer. Cancers 2020, 12, 2554.
https://doi.org/10.3390/cancers12092554
AMA Style
Seo Y, Kim J, Park SJ, Park JJ, Cheon JH, Kim WH, Kim TI.
Metformin Suppresses Cancer Stem Cells through AMPK Activation and Inhibition of Protein Prenylation of the Mevalonate Pathway in Colorectal Cancer. Cancers. 2020; 12(9):2554.
https://doi.org/10.3390/cancers12092554
Chicago/Turabian Style
Seo, Yoojeong, Janghyun Kim, Soo Jung Park, Jae Jun Park, Jae Hee Cheon, Won Ho Kim, and Tae Il Kim.
2020. "Metformin Suppresses Cancer Stem Cells through AMPK Activation and Inhibition of Protein Prenylation of the Mevalonate Pathway in Colorectal Cancer" Cancers 12, no. 9: 2554.
https://doi.org/10.3390/cancers12092554
APA Style
Seo, Y., Kim, J., Park, S. J., Park, J. J., Cheon, J. H., Kim, W. H., & Kim, T. I.
(2020). Metformin Suppresses Cancer Stem Cells through AMPK Activation and Inhibition of Protein Prenylation of the Mevalonate Pathway in Colorectal Cancer. Cancers, 12(9), 2554.
https://doi.org/10.3390/cancers12092554